MiRXES is a Singapore headquartered biotechnology company founded in 2014 by three inspiring Scientist-Entrepreneurs. Spun off from a university lab with the support from A*Star, Prof. Too Heng Phon, Dr. Zhou Lihan and Dr. Zou Ruiyang strived to bring innovative, cutting-edge assay technologies and products for the detection of miRNA to research labs and clinics.
We partner with multinational pharmaceutical companies and world-renown clinical institutions to develop next-generation blood-based cancer diagnostic and prognostic tests.
To advance miRNA technologies to empower translational R&D
Identify novel miRNA disease biomarkers in biofluids and tissues
Develop non-invasive cancer screening and diagnostic tests.